Literature DB >> 25278372

Pentacyclic triterpenoids from spikes of Prunella vulgaris L. inhibit glycogen phosphorylase and improve insulin sensitivity in 3T3-L1 adipocytes.

Qian Yu1, Jin Qi, Lu Wang, Shou-Jin Liu, Bo-Yang Yu.   

Abstract

Phytochemical investigation of methanol extract from the spikes of Prunella vulgaris L. led to the isolation of two new pentacyclic triterpenoid glycosides Vulgasides I (1) and II (2) along with 13 known compounds (3-15). Their structures were established on the basis of nuclear magnetic resonance (1D and 2D) and mass spectroscopic data analysis. All the isolated compounds were screened for glycogen phosphorylase inhibitory activity and also evaluated for their effect on insulin sensitivity in 3T3-L1 adipocytes. Two new compounds (1, 2) did not demonstrate the glycogen phosphorylase inhibitory activity, but other compounds (3-11) exhibited varying degrees of glycogen phosphorylase inhibitory activity with IC50 values in the range from 30.69 to 68.85 μM. Compounds 3, 6, 7, 11, and 13 demonstrated markedly increased insulin-mediated glucose consumption in 3T3-L1 adipocytes.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Lamiaceae/Labiatae; Prunella vulgaris L; glycogen phosphorylase; insulin sensitivity; pentacyclic triterpenoid

Mesh:

Substances:

Year:  2014        PMID: 25278372     DOI: 10.1002/ptr.5228

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  2 in total

1.  Oral Administration of Prunella vulgaris L Improves the Effect of Taxane on Preventing the Progression of Breast Cancer and Reduces Its Side Effects.

Authors:  Jixue Zhao; Degang Ji; Xujie Zhai; Lirong Zhang; Xiao Luo; Xin Fu
Journal:  Front Pharmacol       Date:  2018-08-03       Impact factor: 5.810

Review 2.  Prunella vulgaris L. - A Review of its Ethnopharmacology, Phytochemistry, Quality Control and Pharmacological Effects.

Authors:  Junying Pan; Haoyu Wang; Yinghua Chen
Journal:  Front Pharmacol       Date:  2022-06-23       Impact factor: 5.988

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.